Effects of the Covid-19 Pandemic in the 3rd Line Eye Clinic

Yıl 2022, Cilt: 5 Sayı: 1, 1 - 11, 28.04.2022

Müge Fırat

https://doi.org/10.51536/tusbad.957937

Cited By: 1

Öz

Objective: The aim of this study is to determine quantitatively the decrease in the Covid-19-related changes in outpatient admissions and surgery volume during the peak periods of the pandemic, and to examine the patient characteristics related to this decrease.
Methods: In this retrospective cross-sectional study conducted in a large tertiary hospital, patients admitted and examined in April 2020 were examined. The number and characteristics of these data were compared with the data for the same period of 2019.
Results: A total of 8148 patients were admitted to our clinic during the 2019 study period that were 3681 (45.2%) male and were 4467 (54.8%) female. During the 2020 study period, patients had dropped to 817 that were 491 (60.1%) male and were 326 (39,9%) female. There was a significant gender difference between the periods. There was an overall decrease of 89.97% in patient admissions. There was no significant difference between the periods in terms of age (42.62 ± 23.47 and 42.24 ± 18.54). In order of the top 3 patients in 2020; Conjunctivitis: 203 (24.84%), refractive error: 113 (13.83%), blepharitis: 112 (13.7%), while the first 3 diagnostic refractive errors in 2019: 1728 (21.21%), conjunctivitis: 1473 (18.07%), presbyopia: 1419 (17.41%). A total of 7 patients underwent surgery in 2020, and 269 patients in 2019. While the decrease in the number of intravital injections was 90.52%, the total decrease in the number of surgeries was 97.08%.
Conclusion: During the peak period of the pandemic, there was a significant decrease in the number of outpatients and surgical procedures. The changes in the frequency and characteristics of eye diseases were observed. Knowing the characteristics and changes of eye diseases during the pandemic period will shed light on the measures to be taken in the future.

Anahtar Kelimeler

Covid-19, Ophthalmology, Pandemic

Covid-19 Pandemisinin 3. Basamak Göz Kliniğinde Etkileri

Öz

Amaç: Bu çalışmanın amacı, pandeminin en yoğun olduğu dönemlerde göz hastalıkları polikliniğine ayaktan hasta başvuruları ve ameliyat hacmindeki Covid-19'a bağlı düşüşün nicel olarak belirlenmesini sağlamakla birlikte bu azalmaya bağlı hasta özelliklerini incelemektir.
Yöntem: Büyük bir üçüncü basamak hastanede yapılan bu retrospektif kesitsel çalışmada, Nisan 2020'de başvuran ve muayene edilen hastalar incelenmiştir. Bu verilerin sayısı ve özellikleri 2019 yılının aynı dönemine ait verilerle karşılaştırılmıştır.
Bulgular: 2019 çalışma döneminde kliniğimize başvuran toplam 8148 hasta vardı. Hastaların 3681’i (45,2%) erkek, 4467’si (54,8%) kadındı. 2020 çalışma döneminde, hastalar 817'ye düşmüştü. Hastaların 491’i (60,1%) erkek, 326’sı (39,9%) kadındı. İki dönem arasında cinsiyete göre anlamlı farklılık vardı. Hasta başvurusunda ise %89,97 oranında genel azalma mevcuttu. Ortalama yaş 2019 döneminde 42,62 ± 23,47 (0–102 yaş aralığında) ve 2020 döneminde 42,24 ± 18,54 (0-99 yaş aralığında) olarak bulundu. Yaş bakımından dönemler arasında anlamlı farklılık yoktu. 2020’deki ilk 3 tanı hasta sayısı sırasıyla; konjonktivit:203 (%24,84), refraksiyon kusuru:113 (%13,83), blefarit:112 (%13,7) iken 2019’daki ilk 3 tanı refraksiyon kusuru:1728 (%21,21), konjonktivit:1473 (%18,07), presbiyopi:1419 (%17,41) idi. 2020 döneminde toplam 7 hasta, 2019 yılında ise 269 hasta ameliyat oldu. İntraviteral enjeksiyon sayısındaki azalma % 90,52 olarak bulunurken hastaneye yatış ve ameliyat sayılarındaki toplam azalma oranı %97,08'dir.
Sonuç: Pandemi pik döneminde polikliniklere ayaktan başvuran hasta sayısında ve cerrahi işlemlerde azalma olmuştur. Bu dönemde göz hastalıklarının özellikleriyle sıklıklarında değişiklikler görülmüştür.

Anahtar Kelimeler

covid 19, oftalmoloji, pandemi

Kaynakça

• 1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239– 1242.
• 2. WHO Director-General’s opening remarks at the media briefing on COVID19 -March 2020.
• 3. COVID-19 (SARS-Cov-2 Enfeksiyonu) Rehberi Bilim Kurulu Çalışması https://covid19.saglik.gov.tr/ T.C. Sağlık Bakanlığı 14 Nisan 2020, Ankara.
• 4. American Academy of Ophthalmology (updated 2020, April 17). Recommendations for urgent and nonurgent patient care. 2020. [accessed 2020 May 29]. Available from: https://www.aao.org/headline/ new-recommendations-urgent-nonurgent-patient-care.].
• 5. Pellegrini M, Roda M, Lupardi E, Di Geronimo N, Giannaccare G, Schiavi C. The impact of COVID‐19 pandemic on ophthalmological emergency department visits. Acta Ophthalmologica 2020.
• 6. Kutlu Ö, Güneş R, Coerdt K, Metin A, Khachemoune A. The effect of the “stay‐at‐home” policy on requests for dermatology outpatient clinic visits after the COVID ‐19 outbreak. Dermatologic Therapy 2020.
• 7. Yıldırım M, Güler A. COVID-19 severity, self-efficacy, knowledge, preventive behaviors, and mental health in Turkey. Death Studies published online 2020;1–8. 8. Borrelli E, Grosso D, Vella G, Sacconi R, Querques L, Zucchiatti I et al. Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let’s be ready for a plausible “rebound effect”. Graefes Arch Clin Exp Ophthalmol 2020;258, 2655–2660.
• 9. Pelletier AL, Rojas-Roldan L, Coffin J. Vision Loss in Older Adults. Am Fam Physician. 2016;94(3):219-226.
• 10. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395(10229):1054–1062.
• 11. Li S, Feng B, Liao W, Pan W. Internet use, risk awareness, and demographic character?istics associated with engagement in preven?tive behaviors and testing: cross-sectional survey on COVID-19 in the United States. J Med Internet Res. 2020;22(6):e19782.
• 12. Loon SC, Teoh SC, Oon LL, Se-Thoe S-Y, Ling AE,Leo YS et al. The severe acute respiratory syndrome coronavirus in tears. Br J Ophthalmol 2004;88(07): 861–863
• 13. Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020;138(05):575–578 10
• 14. Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020;3
• 15. Wang P, Chen J, Zheng A, Nie Y, Shi X, Wang W et al. Expression cloning functional receptor used by SARS coronavirus. Biochem Biophys Res Commun 2004; 315(2): 439–444.
• 16. Sun Y, Liu L and Pan X. Binding action between SARSCoV S666 protein and ACE2 receptor in eyes. Rec Adv Ophthalmol 2007; 27(4): 250–253
• 17. Zhou Y, Zeng Y, Tong Y, Chen C. Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. MedRxiv 2020. 2002.2011.20021956.
• 18. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet 2020; 395(10224): e39.
• 19. Alert: Important coronavirus context for ophthalmologists. American Academy of Ophthalmology, https:// www.aao.org/headline/alert-important-coronavirus-context 2020, accessed 18 Feb 2020
• 20. Coronavirus kills Chinese whistleblower ophthalmologist. American Academy of Ophthalmology, https://www. aao.org/headline/coronavirus-kills-chinese-whistleblowerophthalmol (2020, accessed 15 February 2020
• 21. Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE. Assessing viral shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020;127:977–9.
• 22. Aytoğan H, Ayintap E, Özkalay Yilmaz N. Detection of coronavirus disease 2019 viral material on environmental surfaces of an ophthalmology examination room. JAMA Ophthalmol 2020. Published online August 3.
• 23. File TM, Tsang KWT. Severe acute respiratory syndrome: pertinent clinical characteristics and therapy. Treat Respir Med. 2005;4 (2):95–106.
• 24. Subhash SS, Baracco G, Miller SL, Eagan A, Radonovich LJ. Estimation of needed isolation capacity for an airborne influenza pandemic. Heal Secur. 2016;14(4):258–63.
• 25. Razzaki S, Baker A, Perov Y, Middleton K, Baxter J, Mullarkey D et al. A Comparative Study of Artificial Intelligence and Human Doctors for the Purpose of Triage and Diagnosis. London: Babylon Health;2018